Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 27.35 CNY -2.15% Market Closed
Market Cap: 6.5B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

Sirio Pharma Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sirio Pharma Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Cash & Cash Equivalents
ÂĄ521.9m
CAGR 3-Years
34%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cash & Cash Equivalents
ÂĄ21B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
1%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Cash & Cash Equivalents
ÂĄ460m
CAGR 3-Years
25%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Cash & Cash Equivalents
ÂĄ4B
CAGR 3-Years
42%
CAGR 5-Years
32%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cash & Cash Equivalents
ÂĄ3.3B
CAGR 3-Years
22%
CAGR 5-Years
13%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cash & Cash Equivalents
ÂĄ2.5B
CAGR 3-Years
90%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
6.5B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
35.1 CNY
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
521.9m CNY

Based on the financial report for Dec 31, 2023, Sirio Pharma Co Ltd's Cash & Cash Equivalents amounts to 521.9m CNY.

What is Sirio Pharma Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
49%

Over the last year, the Cash & Cash Equivalents growth was -62%. The average annual Cash & Cash Equivalents growth rates for Sirio Pharma Co Ltd have been 34% over the past three years , 49% over the past five years .

Back to Top